Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Small Cell Lung Carcinoma × camrelizumab × Clear all

Phase

Status

Sponsor Class

UNKNOWN 1 OTHER_GOV 1 OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Esophageal Squamous Cell Carcinoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

apatinib 2 Etoposide 2 tislelizumab 1 camrelizumab 1 anlotinib 1 Radiotherapy 1 Irinotecan 1 Immunotherapy 1 Drug Therapy 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04683198 2020-12-24

Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC

ChineseAMS

Phase 2 Unknown

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡